Pfizer, Inc. (PFE) Tops Q2 EPS by 8c; Reaffirms Outlook; to File IPO for Animal Health Unit

July 31, 2012 7:01 AM EDT Send to a Friend
Pfizer, Inc. (NYSE: PFE) reported Q2 EPS of $0.62, $0.08 better than the analyst estimate of $0.54. Revenue for the quarter came in at $15.1 billion versus the consensus estimate of $14.9 billion.

Sees filing IPO for 20% stake in Animal Health unit.

Pfizer, Inc. reaffirmed FY2012 guidance.

For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Earnings, Guidance, Hot Earnings, IPOs

Related Entities

Earnings

Add Your Comment